Bozcuk H - Search Results

1

The value of low-dose intraperitoneal immunoglobulin administration in the treatment of peritoneal dialysis-related peritonitis.

Coban E, Ozdogan M, Tuncer M, Bozcuk H, Ersoy F. Coban E, et al. Among authors: bozcuk h. J Nephrol. 2004 May-Jun;17(3):427-30. J Nephrol. 2004. PMID: 15365965 Clinical Trial.

2

Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients.

Gligorov J, Ataseven B, Verrill M, De Laurentiis M, Jung KH, Azim HA, Al-Sakaff N, Lauer S, Shing M, Pivot X; SafeHer Study Group. Gligorov J, et al. Eur J Cancer. 2017 Sep;82:237-246. doi: 10.1016/j.ejca.2017.05.010. Epub 2017 Jun 16. Eur J Cancer. 2017. PMID: 28625777 Clinical Trial.

3

Transfer of native insulin through the peritoneal membrane during CAPD in non-diabetic and diabetic patients.

Ersoy FF, Karayalcin U, Karayalcin B, Sapan M, Bozcuk H, Süleymanlar G, Yakupoglu G. Ersoy FF, et al. Among authors: bozcuk h. Adv Perit Dial. 1995;11:119-22. Adv Perit Dial. 1995. PMID: 8534683

4

Effect of cefodizime on peritoneal mononuclear- and polymorphonuclear-cell chemotaxis.

Ustün H, Ersoy FF, Sezer T, Ozcan S, Bozcuk H, Yegin O, Balci M, Süleymanlar G, Yakupoglu G. Ustün H, et al. Among authors: bozcuk h. Adv Perit Dial. 1998;14:154-7. Adv Perit Dial. 1998. PMID: 10649715

5

Predictors of distant metastasis at presentation in breast cancer: a study also evaluating associations among common biological indicators.

Bozcuk H, Uslu G, Peştereli E, Samur M, Ozdoğan M, Karaveli S, Sargin F, Savaş B. Bozcuk H, et al. Breast Cancer Res Treat. 2001 Aug;68(3):239-48. doi: 10.1023/a:1012269804578. Breast Cancer Res Treat. 2001. PMID: 11727960

6

Does awareness of diagnosis make any difference to quality of life? Determinants of emotional functioning in a group of cancer patients in Turkey.

Bozcuk H, Erdoğan V, Eken C, Ciplak E, Samur M, Ozdoğan M, Savaş B. Bozcuk H, et al. Support Care Cancer. 2002 Jan;10(1):51-7. doi: 10.1007/s005200100308. Support Care Cancer. 2002. PMID: 11777189

7

Durable remission of leptomeningeal metastasis of breast cancer with letrozole: a case report and implications of biomarkers on treatment selection.

Ozdogan M, Samur M, Bozcuk HS, Sagtas E, Yildiz M, Artac M, Savas B. Ozdogan M, et al. Jpn J Clin Oncol. 2003 May;33(5):229-31. doi: 10.1093/jjco/hyg046. Jpn J Clin Oncol. 2003. PMID: 12865466

8

The value of CEA and CA 19-9 in detecting cancer in a group of high-risk subjects with gastrointestinal symptoms.

Coban E, Samur M, Bozcuk H, Ozdogan M. Coban E, et al. Among authors: bozcuk h. Int J Biol Markers. 2003 Jul-Sep;18(3):177-81. doi: 10.1177/172460080301800304. Int J Biol Markers. 2003. PMID: 14535587 Free article.

9

"Do not tell": what factors affect relatives' attitudes to honest disclosure of diagnosis to cancer patients?

Ozdogan M, Samur M, Bozcuk HS, Coban E, Artac M, Savas B, Kara A, Topcu Z, Sualp Y. Ozdogan M, et al. Support Care Cancer. 2004 Jul;12(7):497-502. doi: 10.1007/s00520-004-0633-2. Epub 2004 Apr 16. Support Care Cancer. 2004. PMID: 15088138

10

Tumour necrosis factor-alpha, interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy.

Bozcuk H, Uslu G, Samur M, Yildiz M, Ozben T, Ozdoğan M, Artaç M, Altunbaş H, Akan I, Savaş B. Bozcuk H, et al. Cytokine. 2004 Jul 21-Aug 7;27(2-3):58-65. doi: 10.1016/j.cyto.2004.04.002. Cytokine. 2004. PMID: 15242694

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

96 results

Search Page

Filters